ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

---

Autoria(s): McMurray J.J.; Adamopoulos S.; Anker S.D.; Auricchio A.; Böhm M.; Dickstein K.; Falk V.; Filippatos G.; Fonseca C.; Gomez-Sanchez M.A.; Jaarsma T.; Køber L.; Lip G.Y.; Maggioni A.P.; Parkhomenko A.; Pieske B.M.; Popescu B.A.; Rønnevik P.K.; Rutten F.H.; Schwitter J.; Seferovic P.; Stepinska J.; Trindade P.T.; Voors A.A.; Zannad F.; Zeiher A.; ESC Committee for Practice Guidelines

Data(s)	2012
Identificador	https://serval.unil.ch/?id=serval:BIB_11898AB8A634 isbn:1522-9645 (Electronic) pmid:22611136 doi:10.1093/eurheartj/ehs104 isiid:000306683100019
Idioma(s)	en
Direitos	Restricted: indefinite embargo info:eu-repo/semantics/restrictedAccess
Fonte	European Heart Journal, vol. 33, no. 14, pp. 1787-1847
Palavras-Chave	#Acute Disease; Algorithms; Anti-Arrhythmia Agents/therapeutic use; Arrhythmias, Cardiac/therapy; Cardiac Imaging Techniques; Cardiac Resynchronization Therapy/methods; Cardiotonic Agents/therapeutic use; Chronic Disease; Clinical Laboratory Techniques; Comorbidity; Defibrillators, Implantable; Diuretics/therapeutic use; Drug Combinations; Electrocardiography; Exercise Test; Fatty Acids, Omega-3/therapeutic use; Genetic Testing/methods; Heart Failure/complications; Heart Failure/diagnosis; Humans; Natriuretic Peptides/metabolism; Prognosis; Stroke Volume/physiology; Terminology as Topic; Therapies, Investigational/methods; Thromboembolism/prevention & control; Ventricular Dysfunction, Left/diagnosis
Tipo	info:eu-repo/semantics/review article